Next, we examined both normal and tumor breast tissue samples from four patients with highly aggressive grade 3 breast adenocarcinoma, for the expression levels of CD44 and CD146, by immunohistochemical analysis. The gene discussed is MCAM; the disease is breast adenocarcinoma.